Increased suicide attempt rate among patients interrupting use of atypical antipsychotics
Open accessThe DOI matches its Crossref record.
Abstract
Purpose: The aim of the study is to investigate whether patients at risk to commit suicide could be identified based on their drug refill patterns. Methods: Data for this study were obtained from the PHARMO system comprising drug‐dispensing data linked to hospital discharge records. All patients aged 15–45 years, suspected to suffer from schizophrenia and exclusive users of olanzapine or risperidone were selected. The use of antipsychotics was converted into treatment episodes of uninterrupted use. Therapy non‐compliance was defined as a drug holiday of at least 30 days. The follow‐up started with a treatment episode of at least 90 days. Relative risks for suicide attempts and 95% confidence limits due to drug holidays were estimated using Poisson regression analyses. Results: Of 603 patients, 33% interrupted treatment for at least 30 days. An increased suicide attempt rate was observed when comparing uninterrupted and interrupted drug use (20.0/1000 person years vs 72.1/1000 person years, respectively). A four‐fold increased risk for attempting suicide among patients with drug holidays was found (RR adjusted for age and gender 4.2, 95%CI: 1.7–10.1) compared to patients without drug holidays. Conclusions: Patients who do not refill atypical antipsychotics in time can be identified in the pharmacy and are most likely those with an increased risk to commit suicide. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
Haddad, P., Brain, C., & Scott, J. (2014) · Patient Related Outcome Measures · doi:10.2147/prom.s42735 · Cited by 585
Novick, D., Haro, J. M., Suarez, D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.004 · Cited by 447
Kane, J. M., Sanchez, R., Perry, P. P., Jin, N., Johnson, B. R., Forbes, R. A., McQuade, R. D., Carson, W. H., & Fleischhacker, W. W. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07530 · Cited by 361
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
Pompili, M., Baldessarini, R., Forte, A., Erbuto, D., Serafini, G., Fiorillo, A., Amore, M., & Girardi, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101700 · Cited by 78
“Finally, it has been reported that discontinuing antipsychotic drug treatment, including olanzapine or risperidone, can be followed by an increase in suicide attempt rates [54].”
BackgroundSuicidal Behavior in Mood Disorders: Response to Pharmacological Treatment
Tondo, L., & Baldessarini, R. J. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0715-0 · Cited by 71
Geerts, P., Martinez, G., & Schreiner, A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-58 · Cited by 48
“Ensuring treatment continuation through improved adherence is therefore a major objective in the treatment of schizophrenia and can impact on morbidity [6,8-11], attempted suicide [6,12], severity of violent behaviour [13], and patient satisfaction [9] as well as direct and indirect healthcare costs [14-16].”
BackgroundCompleted Versus Attempted Suicide in Psychiatric Patients: a Psychological Autopsy Study
INNAMORATI, M., POMPILI, M., MASOTTI, V., PEARSONÉI, F., LESTER, D., TATARELLI, R., GIRARDI, P., & AMORE, M. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000327311.04153.01 · Cited by 34
Metadata
- Authors
- Herings, R. M. C., & Erkens, J. A.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2003-05-06
- Volume
- 12
- Issue
- 5
- Pages
- 423-424
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W1997763686
- Cited by
- 119
- References
- 0
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.